Pelage Pharmaceuticals
Series BPelage Pharmaceuticals is a privately held company based in United States, founded in 2018. The latest disclosed round is Series B ($120m), dated Sep 18, 2025. Institutional investors on record include Google Ventures.
United States · EST 2018
What is Pelage Pharmaceuticals?
Pelage Pharmaceuticals is a privately held company based in United States, founded in 2018. The latest disclosed round is Series B ($120m), dated Sep 18, 2025. Institutional investors on record include Google Ventures. Developer of therapeutics for hair loss treatment in men and women. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
Which funds backed Pelage Pharmaceuticals?
Who invested in Pelage Pharmaceuticals?
Funds on the dated round table. Open a name to read the fund card.
| Investor | Round | Amount | Date |
|---|---|---|---|
| Google Ventures | Series B | $120m | Sep 18, 2025 |
What do founders ask about Pelage Pharmaceuticals?
What is Pelage Pharmaceuticals?
Pelage Pharmaceuticals is a privately held company based in United States, founded in 2018. The latest disclosed round is Series B ($120m), dated Sep 18, 2025. Institutional investors on record include Google Ventures. Developer of therapeutics for hair loss treatment in men and women. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
What was Pelage Pharmaceuticals's last funding round?
Pelage Pharmaceuticals's latest disclosed round is Series B at $120m (Sep 18, 2025).
Who invested in Pelage Pharmaceuticals?
Pelage Pharmaceuticals has 1 institutional investors on this page, including Google Ventures.
How does CrackTheDeck cover Pelage Pharmaceuticals?
This startup card lists dated rounds and linked fund profiles so founders can see who is already in the cap table before a pitch.
How is this page compiled?
Round, amount, and investor names on the Pelage Pharmaceuticals card come from dated financings linked to fund profiles in CrackTheDeck. Empty fields mean the figure was not in those records. Updated Aug 2026.